Featured Stories
Metal-on-Metal Hip Replacement Concerns Grow in Canada

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Medtronic Settles Charges Over Kickbacks To Doctors

Medical device giant, Medtronic Inc., is settling charges over kickbacks to doctors. The firms just agreed to pay $23.5 million to settle claims it paid physicians kickbacks in exchange for their use of its pacemakers and defibrillators, according to a U.S. Justice Department announcement yesterday. The company was accused of seeking ...

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher’s Financial Ties to Takeda

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

FDA Warns About Supplement Claims to Treat, Cure Concussions

The U.S Food and Drug Administration (FDA) just issued a warning concerning supplement claims to treat or cure concussions.

According to the agency, no proof exists that dietary supplements treat or cure concussions, according to KSBY.com. Also, while supplements may not contain dangerous ingredients, experts point out that the bogus claims may convince athletes, coaches, or parents that the injured person is ready to return to normal activities before it is safe to do so.

The FDA warns that, with school starting, football, soccer, and other sports practices may be beginning and that there is the potential for injuries due to violent jarring and shocks. The FDA also notes that some supplement makers are offering untested and unproven products that may be dangerous and that claim to prevent, treat, or cure traumatic brain injuries (TBIs), such as concussions. The FDA described these marketing practices as exploiting the public’s mounting concern about these injuries. Continue reading

Posted in Pharmaceuticals |

Sexual Assault Allegations Involve Ultra-Orthodox Rabbi, Israel-Based Seminaries for Girls

A federal lawsuit filed over sexual assault allegations tied to Rabbi Elimelech Meisels of an ultra-Orthodox community in Chicago, follows similar allegations brought before rabbinical courts in both Chicago and Israel, so called “beis din” courts.

The federal allegations involve that Meisels, who runs Israel-based seminaries for girls, is a sexual predator, according to The Chicago Tribune. The federal lawsuit was filed by the parents of female students who seek tuition reimbursement given allegations against Meisels that include that, for 10 years, the rabbi recruited young women from cities such as Chicago to attend his Israel-based seminaries “under the guise of educational and spiritual development.” The lawsuit also accuses the rabbi of “developing mentor-mentee relationships with girls,” and bringing them on late-night coffee meetings, then sexually assaulting the young women. Meisels does not face any criminal charges, The Chicago Tribune noted. Continue reading

Posted in Child Sexual Abuse, Legal News |

Deadline Approaching to Register World Trade Center Compensation Claims

-World-Trade-Center-Compensation-ClaimsThe September 11 Victim Compensation Fund has an important filing deadline on October 12, 2014 for those who took part in World Trade Center rescue and recovery efforts in 2001-2002 and now suffer cancers and other illnesses caused by toxic exposure.

Those who were diagnosed on or before October 12, 2012 with one of the cancers recognized by the VCF by that date must register with the VCF by October 12, 2014, according to The PBA Beat, the New York Patrolmen’s Benevolent Association newsletter.  Participants in the recovery efforts who were diagnosed on or before October 21, 2013 with prostate cancer must register by October 21, 2015. Those diagnosed on or before February 18, 2014 with a “rare cancer” (as defined by the WTC Health Program) must register by February 18, 2016. Anyone diagnosed with one of the recognized cancers after the cut-off dates above may register up to two years after the date they became ill, but no later than October 3, 2016. Continue reading

Posted in Health Concerns, Legal News, Toxic Substances, Zadroga Act Claims |

Lawsuit Alleging Yeshiva High School Covered Up Sexual Abuse May be Reinstated

Lawsuit-Alleging-Yeshiva-High-SchoolLast Thursday, a federal appeals court was asked to reinstate a lawsuit filed on behalf of 34 men who allege that they were sexually abused by rabbis at Yeshiva University High School for Boys; according to their lawsuit, the school covered up the abuse for decades.

The case was previously dismissed by federal judge John G. Koeltl, who ruled that the abuse had taken place too long ago for the lawsuit to proceed. Attorneys for the plaintiffs argued that the judge misinterpreted the statute of limitations. It was not known that the school helped hide the abuse until December 2012, when The Daily Forward published an article, the plaintiffs’ attorney said. Continue reading

Posted in Legal News |

Putting Cell Phone in Your Bra could Lead to Breast Cancer, Dr. Oz Warns

Cell-Phone-in-Your-BraDr. Mehmet Oz is warning against placing your cell phone in your bra, a habit that many women do out of convenience. “When it comes to cell phones, the bra has become the new purse,” Dr. Oz said on an episode of the Dr. Oz show that aired Aug. 26th. Continue reading

Posted in Legal News |

Supreme Court Rejection of Pfizer RICO Case Appeal Could Unleash Cases

PfizerThe US Supreme Court’s rejection of  an appeal from drug maker Pfizer, letting stand a First Circuit ruling that the drug company improperly marketed the epilepsy drug Neurontin to Kaiser Foundation Health Plan, could unleash a flood of cases

Pfizer must pay Kaiser $142 million in damages for violating the Racketeer Influenced and Corrupt Organizations (RICO) Act and an additional $65.4 million for violating the California Unfair Competition Law (UCL). Continue reading

Posted in Health Concerns, Pharmaceuticals |

Drug Maker, Teva, Recalls Parkinson’s Disease Medication as it may be “Super Potent”

tevaTeva Pharmaceutical Industries just issued a recall of one lot of its generic Parkinson’s disease combination medication, carbidopa/levodopa, over it potentially containing too much of an active pharmaceutical ingredient.

Teva Pharmaceutical Industries indicated that the recall, which has been deemed a Class II, involved 3,881 bottles of carbidopa/levodopa 25 mg/100 mg, according to FiercePharmaManufacturing. Teva also indicated that stability testing revealed that the recalled carbidopa/levodopa may be what the drug maker described as “super potent.” The voluntary recall is for the entire United States. Continue reading

Posted in Pharmaceuticals, Product Recalls |

Researchers Study Whether Chemicals in the Environment Increase the Risk of Diabetes

Diabetes ConceptResearchers at the University of Buffalo will be studying how chemicals in the environment affect the risk of diabetes and metabolic conditions.  According to an article posted on the university’s website, the National Institute of Environmental Health Sciences has awarded a two-year $436,751 grant to Margarita L. Dubocovich, PhD and Rajendram V. Rajnarayanan, PhD to study this issue.   Continue reading

Posted in Legal News |

FDA Issues Injunction Against BioAnue Laboratories

FDA-Issues-Injunction-Against-BioAnue-LaboratoriesA federal court order demands that BioAnue Laboratories of Rochelle, Georgia stops illegally marketing its products as treatments for disease, the U.S. Food and Drug Administration (FDA) announced on its website. The court order, which was signed on July 23, 2014 in the United States District Court for the Middle District of Georgia, says that BioAnue’s products were sold as supplements but were illegally marketed as treatments for conditions such as cancer, HIV/AIDS, heart disease, chronic obstructive pulmonary disease and diabetes. The FDA did not approve these products for those uses.

In February 2012, the FDA issued a warning lette Continue reading

Posted in Legal News |

Government Will Withhold Up to One Third of Payment Records in Launch of Physician Payment Database

Launch-of-Physician-Payment-DatabaseFor next month’s launch of the Open Payment database showing payments to physicians from pharmaceutical companies and medical device makers, about one-third of the records will be withheld because of data inconsistencies.

The release of payment information – intended to promote greater transparency about possible conflicts of interest in medicine – is mandated under the Physician Payment Sunshine Act, a provision of the 2010 Affordable Care Act, according to the non-profit investigative journalism group ProPublica. Continue reading

Posted in Legal News |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.